| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 70696 |
用于DNA/RNA递送的DC胆固醇脂质体,定制服务 |
95 |
axc |
2024-12-23 |
| 70697 |
Cl-C6-PEG6-NHCO-C3-NHS，氯-C6-六聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
151 |
h |
2024-12-23 |
| 70698 |
用于DNA/RNA递送的GL-67脂质体,定制服务 |
139 |
axc |
2024-12-23 |
| 70699 |
cas:1824718-79-7，SPDH，N-succinimidyl-6-(2-pyridyldithio)capronate-ADC连接子 |
110 |
zyl |
2024-12-23 |
| 70700 |
标准氯膦酸盐脂质体试剂盒(阴离子，含有对照脂质体)，Standard Clodronate Liposomes Kits (Anionic, contain control liposomes) |
297 |
axc |
2024-12-23 |
| 70701 |
Standard Clodronate Liposomes Kits (Neutral, contain control liposomes)，标准氯屈膦酸盐脂质体试剂盒（中性，含有对照脂质体） |
109 |
axc |
2024-12-23 |
| 70702 |
cas:890409-85-5，2,5-dioxopyrrolidin-1-yl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate |
138 |
zyl |
2024-12-23 |
| 70703 |
标准普通对照脂质体(阴离子),Standard Plain Control Liposomes (Anionic) |
106 |
axc |
2024-12-23 |
| 70704 |
Tetrazine-Ph-NHCO-C3-NHS ester，四嗪-PH-NHCO-C3-琥珀酰亚胺酯,1244040-64-9 |
102 |
h |
2024-12-23 |
| 70705 |
cas:452072-27-4 Sulfo-SPP-可作ADC的连接剂 |
72 |
zyl |
2024-12-23 |
| 70706 |
标准氯膦酸盐脂质体(阴离子),Standard Clodronate Liposomes (Anionic) |
85 |
axc |
2024-12-23 |
| 70707 |
Boc-NH-PEG12-C3-acid，BOC-氨基-十二乙二醇-C3-羧酸 |
94 |
h |
2024-12-23 |
| 70708 |
标准普通对照脂质体(中性),Standard Plain control Liposomes (Neutral) |
146 |
axc |
2024-12-23 |
| 70709 |
CAS号1628113-16-5 SPDB-sulfo-ADC抗体偶联药物 |
124 |
zyl |
2024-12-23 |
| 70710 |
Standard Clodronate Liposomes (Neutral),标准氯膦酸盐脂质体(中性) |
120 |
axc |
2024-12-23 |
| 70711 |
Standard-Clodronate-Liposomes，标准氯膦酸盐脂质体 |
126 |
axc |
2024-12-23 |
| 70712 |
cas:186023-44-9 Fmoc-Ala-Pro-OH |
104 |
zyl |
2024-12-23 |
| 70713 |
cas:1343407-91-9 Alloc-Val-Ala-PAB |
106 |
zyl |
2024-12-23 |
| 70714 |
cas:1394238-91-5 Fmoc-Val-Ala-PAB-ADC连接子 |
141 |
zyl |
2024-12-23 |
| 70715 |
甘露糖基氯膦酸盐脂质体试剂盒，Mannosylated Clodronate Liposome Kits |
124 |
axc |
2024-12-23 |
| 70716 |
cas:1884577-99-4 Boc-Val-Ala-PAB-ADC抗体偶联药物 |
133 |
zyl |
2024-12-23 |
| 70717 |
Boc-NH-PEG10-C3-acid，BOC-氨基-十乙二醇-C3-羧酸 |
114 |
h |
2024-12-23 |
| 70718 |
Control for Mannosylated Clodronate Liposomes，甘露糖基氯膦酸盐脂质体的控制 |
117 |
axc |
2024-12-23 |
| 70719 |
Boc-NH-PEG5-C3-acid，BOC-氨基-五乙二醇-C3-羧酸 |
107 |
h |
2024-12-23 |
| 70720 |
cas:1870916-87-2 Mal-Val-Ala-PAB-ADC连接子 |
111 |
zyl |
2024-12-23 |
| 70721 |
Azide-PEG7-CH2CH2CH2-COOtBu，叠氮PEG7-CH2CH2CH2-COOtBu |
105 |
h |
2024-12-23 |
| 70722 |
Azide-PEG3-CH2CH2CH2-COOtBu，叠氮PEG3-CH2CH2CH2-COOtBu |
116 |
h |
2024-12-23 |
| 70723 |
cas:1343476-44-7 Val-Ala-PAB-OH |
148 |
zyl |
2024-12-23 |
| 70724 |
Azide-PEG4-CH2CH2CH2-COOtBu，叠氮PEG4-CH2CH2CH2-COOtBu |
84 |
h |
2024-12-23 |
| 70725 |
甘露糖基化氯膦酸盐脂质体，Mannosylated-Clodronate-Liposomes |
124 |
axc |
2024-12-23 |
| 70726 |
Thiol-PEG4-t-butyl ester，CAS：564476-33-1 |
101 |
h |
2024-12-23 |
| 70727 |
Cy7.5-CONH-(C1-CONH-C2-Mal)-C4-DOTA，CY7.5标记的大环化合物 |
81 |
h |
2024-12-23 |
| 70728 |
冻干氯膦酸盐脂质体(阴离子)的质控品，Control for Lyophilized Clodronate Liposome (Anionic) |
144 |
axc |
2024-12-23 |
| 70729 |
cas:2762518-86-3 NHS ester-PEG4-Val-Cit-PAB-MMAE的合成方法 |
155 |
zyl |
2024-12-23 |
| 70730 |
cas:1350456-56-2 Fmoc-Val-Cit-PAB-MMAE-ADC抗体偶联药物 |
130 |
zyl |
2024-12-23 |
| 70731 |
cas:1869126-64-6 Azido-PEG4-Val-Cit-PAB-MMAE-ADC连接子 |
79 |
zyl |
2024-12-23 |
| 70732 |
Cis-[Pt-1,3-Propanediamine]-2-C4-Azide，1821165-96-1 |
104 |
h |
2024-12-23 |
| 70733 |
冻干氯膦酸盐脂质体(中性)的质控品，Control for lyophilized Clodronate Liposome (Neutral) |
86 |
axc |
2024-12-23 |
| 70734 |
Pomalidomide-NH-C4-NH-Boc，2093388-52-2 |
127 |
h |
2024-12-23 |
| 70735 |
DOTA-(COOt-Bu)3-C4-NH2，1402393-59-2 |
119 |
h |
2024-12-23 |
| 70736 |
cas:1613321-01-9 6-Azidohexanoyl-Val-Cit-PAB一种点击化学试剂 |
93 |
zyl |
2024-12-23 |
| 70737 |
冻干氯膦酸盐脂质体(阴离子)，Lyophilized Clodronate Liposomes (Anionic) |
126 |
axc |
2024-12-23 |
| 70738 |
Thalidomide-O-C4-acid，2169266-67-3 |
94 |
h |
2024-12-23 |
| 70739 |
Biotin-LC-LC-NHS，89889-52-1 |
83 |
h |
2024-12-23 |
| 70740 |
cas:2994332-18-0 DBCO-C4-Val-Cit-PABC-PNP可作ADC的连接剂 |
64 |
zyl |
2024-12-23 |
齐岳微信公众号
官方微信
库存查询